References
- Modarres M, Naseripour M, Falavarjani KG, et al. Intravitreal injection of 2.5 mg versus 1.25 mg bevacizumab (Avastin) for treatment of CNV associated with AMD. Retina 2009;29:319–324
- Gaudio P. A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation. Ocul Immunol Inflamm 2004;12:169–192
- Ueno Y, Futagawa H, Takagi Y, et al. Drug-incorporating calcium carbonate nanoparticles for a new delivery system. J Control Release 2005;103:93–98
- Guenther LC. Fixed-dose combination therapy for psoriasis. Am J Clin Dermatol 2004;5:71–77
- Cipollone G, Nicolai M, Mastroprimiano G, et al. [Betamethasone versus placebo in Peyronie's disease]. Archivio italiano di urologia, andrologia: organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica/Associazione ricerche in urologia 1998;70:165–168
- Mulder EJ, Derks JB, Visser GH. Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. BJOG: Int J Obstet Gynaecol 1997;104:1239–1247
- Shepherd W, Fsadni M, Sunder Raj P. A clinical evaluation of diclofenac-gentamicin combination eye drops in the control of inflammation after cataract surgery. Ocul Immunol Inflamm 1998;6:13–18
- Apt L, Voo I, Isenberg SJ. A randomized clinical trial of the nonsteroidal eyedrop diclofenac after strabismus surgery. Ophthalmology 1998;105:1448–1454
- Phillips R, McLean I, Taylor R, Forrester J. Steroid induced glaucoma: a report of two cases with a review of morbidity and prescribing in general practice. Scot Med J 1990;35:81–84
- Peebo BB, Peebo M, Frennesson C. Relapsing polychondritis: a rare disease with varying symptoms. Acta Ophthalmol Scand 2004;82:472–475
- Williamson J, Gordon A, Wood R, et al. Fungal flora of the conjunctival sac in health and disease. Influence of topical and systemic steroids. Br J Ophthalmol 1968;52:127
- Jackson W, Easterbrook W, Connolly W, Leers W. Treatment of blepharitis and blepharoconjunctivitis: comparison of gentamicin-betamethasone, gentamicin alone and placebo. Can J Ophthalmol 1982;17:153–156
- Nikouei BM, Vahabzadeh SA, Mohajeri SA. Preparation of a molecularly imprinted soft contact lens as a new ocular drug delivery system for dorzolamide. Curr Drug Deliv 2013;10:279–285
- Peng C-C, Kim J, Chauhan A. Extended delivery of hydrophilic drugs from silicone–hydrogel contact lenses containing vitamin E diffusion barriers. Biomaterials 2010;31:4032–4047
- Alvarez-Lorenzo C, Yanez F, Barreiro-Iglesias R, Concheiro A. Imprinted soft contact lenses as norfloxacin delivery systems. J Control Release 2006;113:236–244
- Hiratani H, Alvarez-Lorenzo C. The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems. Biomaterials 2004;25:1105–1113
- Xinming L, Yingde C, Lloyd AW, et al. Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review. Cont Lens Anterior Eye 2008;31:57–64
- White C, Tieppo A, Byrne M. Controlled drug release from contact lenses: a comprehensive review from 1965-present. J Drug Deliv Sci Technol 2011;21:369–384
- McNamara NA, Polse KA, Brand RJ, et al. Tear mixing under a soft contact lens: effects of lens diameter. Am J Ophthalmol 1999;127:659–665
- Creech J, Chauhan A, Radke C. Dispersive mixing in the posterior tear film under a soft contact lens. Ind Eng Chem Res 2001;40:3015–3026
- Hiratani H, Fujiwara A, Tamiya Y, et al. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials 2005;26:1293–1298
- Hillman JS. Management of acute glaucoma with pilocarpine-soaked hydrophilic lens. Br J Ophthalmol 1974;58:674–679
- Ruben M, Watkins R. Pilocarpine dispensation for the soft hydrophilic contact lens. Br J Ophthalmol 1975;59:455–458
- Arthur BW, Hay GJ, Wasan SM, Willis WE. Ultrastructural effects of topical timolol on the rabbit cornea: outcome alone and in conjunction with a gas permeable contact lens. Arch Ophthalmol 1983;101:1607–1610
- Wilson MC, Shields MB. A comparison of the clinical variations of the iridocorneal endothelial syndrome. Arch Ophthalmol 1989;107:1465–1468
- Malaekeh-Nikouei B, Ghaeni FA, Motamedshariaty VS, Mohajeri SA. Controlled release of prednisolone acetate from molecularly imprinted hydrogel contact lenses. J Appl Polym Sci 2012;126:387–394
- Gulsen D, Chauhan A. Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle. Int J Pharm 2005;292:95–117
- Kapoor Y, Chauhan A. Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels. Int J Pharm 2008;361:222–229
- Karlgard C, Wong N, Jones L, Moresoli C. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int J Pharm 2003;257:141–151
- Peng C-C, Burke MT, Carbia BE, et al. Extended drug delivery by contact lenses for glaucoma therapy. J Control Release 2012;162:152–158
- Peng C-C, Burke MT, Chauhan A. Transport of topical anesthetics in vitamin E loaded silicone hydrogel contact lenses. Langmuir 2011;28:1478–1487
- Kim J, Peng C-C, Chauhan A. Extended release of dexamethasone from silicone–hydrogel contact lenses containing vitamin E. J Control Release 2010;148:110–116
- Peng C-C, Chauhan A. Extended cyclosporine delivery by silicone–hydrogel contact lenses. J Control Release 2011;154:267–274
- Ohta Y. Possibility of clinical application of vitamin E to cataract prevention. J Clin Biochem Nutr 2004;35:35–45
- Nagata M, Kojima M, Sasaki K. Effect of vitamin E eye drops on naphthalene-induced cataract in rats. J Ocul Pharmacol Therapeutics 1999;15:345–350
- Kojima M, Shui Y, Murano H, Sasaki K. Inhibition of steroid-induced cataract in rat eyes by administration of vitamin-E ophthalmic solution. Ophthalmic Res 1996;28:64–71
- Ohta Y, Yamasaki T, Niwa T, et al. Preventive effect of topical vitamin E-containing liposome instillation on the progression of galactose cataract. Comparison between 5-week-and 12-week-old rats fed a 25% galactose diet. Exp Eye Res 1999;68:747–755
- Ohta Y, Yamasaki T, Niwa T, Majima Y. Preventive effect of vitamin E-containing liposome instillation on cataract progression in 12-month-old rats fed a 25% galactose diet. J Ocul Pharmacol Ther 2000;16:323–335
- Hsu K-H, Carbia BE, Plummer C, Chauhan A. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy. Eur J Pharm Biopharm 2015;94:312–321
- González-Chomón C, Concheiro A, Alvarez-Lorenzo C. Soft contact lenses for controlled ocular delivery: 50 years in the making. Ther Deliv 2013;4:1141–1161
- Kim J, Conway A, Chauhan A. Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses. Biomaterials 2008;29:2259–2269
- Moore L, Ferreira JT. Ultraviolet (UV) transmittance characteristics of daily disposable and silicone hydrogel contact lenses. Cont Lens Anterior Eye 2006;29:115–122
- Hsu K-H, Lazon de la Jara P, Ariyavidana A, et al. Release of betaine and dexpanthenol from vitamin E modified silicone-hydrogel contact lenses. Curr Eye Res 2014;40:267–273